Tranexamic acid for cesarean delivery: evidence of fibrinolysis?

Am J Obstet Gynecol. 2023 Jan;228(1):111-112. doi: 10.1016/j.ajog.2022.08.031. Epub 2022 Aug 20.

Authors

Sebastian M Seifert¹, Susan M Goobie², Kara G Fields³, Michaela K Farber³

Affiliations

¹ Department of Anesthesiology, Perioperative and Pain Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: sseifert@bwh.harvard.edu.
² Department of Anesthesiology, Critical Care & Pain Medicine, Boston Children's Hospital, Boston, MA.
³ Department of Anesthesiology, Perioperative and Pain Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA.

PMID: 35998744
DOI: 10.1016/j.ajog.2022.08.031

No abstract available

Publication types

Letter

MeSH terms

Antifibrinolytic Agents* / therapeutic use
Blood Loss, Surgical / prevention & control
Cesarean Section
Female
Fibrinolysis
Humans
Pregnancy
Tranexamic Acid* / therapeutic use

Substances

Tranexamic Acid
Antifibrinolytic Agents